AzTrials
AzTrials

Cigarette Smoking-Related CarcinomaNCT07857681

Text Message and Mail Delivery of Tailored Educational Materials to Improve Access to Resources for Smoking Cessation of Menthol Tobacco Cigarettes

A study testing Educational Intervention, Internet-Based Intervention and Smartphone Application-based Intervention in people with Cigarette Smoking-Related Carcinoma, run by Roswell Park Cancer Institute at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This clinical trial compares the impact of receiving educational materials containing relevant content about risks from smoking menthol cigarettes which include links to the New York (NY) Smoke-Free website by text message or mail in people who smoke menthol cigarettes. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Cigarette Smoking-Related Carcinoma
What is being tested?
Educational Intervention, Internet-Based Intervention and Smartphone Application-based Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteUnited States
Study dates
8 Aug 2025to 12 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older
  • Residents of New York State
  • English Speaking
  • Willingness to receive and engage with mailed educational materials
  • Participants with ability to receive text messaging access to smart device

Who cannot join

  • Report currently smoking menthol cigarettes
  • People who do not report currently smoking menthol cigarettes
  • Individuals under 18 years of age
  • Persons in correctional facilities
  • Non-English speaking
  • Participants who cannot receive text messaging or have access to smart device

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Roswell Park Cancer Institute

    Buffalo, New York, 14263

Other trials in United States

About this study

Official title: An Exploratory Investigation on Effectiveness of Tailored New York State Quitline Services for Cessation of Menthol Tobacco Cigarettes

This clinical trial compares the impact of receiving educational materials containing relevant content about risks from smoking menthol cigarettes which include links to the New York (NY) Smoke-Free website by text message or mail in people who smoke menthol cigarettes. The NY Smoke-Free website includes tailored content developed specifically for menthol smokers and provides resources designed to resonate with the experiences of menthol smokers and address the unique challenges they face in quitting. Delivering tailored educational materials by text message or mail may increase interaction with information about menthol cigarettes and smoking cessation resources compared to those who do not receive the educational messaging.

Read the detailed description

PRIMARY OBJECTIVES:

  1. Assess participant interaction with an educational message about menthol cigarettes by tracking visits to the Quitline website.

II. Assess participant interaction with the educational message delivered by text message with a direct link to information about menthol cigarettes by tracking visits to the Quitline Web site.

III. Assess participant interaction with the educational message delivery by mail with a direct link to information about menthol cigarettes by tracking visits to the Quitline Web.

OUTLINE: Participants are randomized to 1 of 3 groups.

GROUP I: Participants receive an educational flyer by mail along with the standard Quitline materials on study. Participants receive access to a website and quick response (QR) code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.

GROUP II: Participants receive standard Quitline materials in the mail on study.

GROUP III: Participants receive an educational message by text along with the standard Quitline materials by mail on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.

Being tested
Educational Intervention, Internet-Based Intervention, Smartphone Application-based Intervention, Smoking Cessation Intervention, Text Message-Based Navigation Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Educational InterventionOther

    Also called Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

    Receive an educational flyer by mail

  • Internet-Based InterventionOther

    Receive access to a website

  • Smartphone Application-based InterventionBehavioural

    Also called Smartphone App-based Intervention, Smartphone Intervention, Smartphone-based Intervention

    Receive access to a QR code

  • Smoking Cessation InterventionBehavioural

    Also called Smoking and Tobacco Use Cessation Interventions

    Receive standard Quitline materials

  • Text Message-Based Navigation InterventionOther

    Also called Automated Text Message-Based Navigation, Text Message-Based Navigation

    Receive an educational message by text

Study groups in NCT07857681
Study groupRoleWhat they receive
Cohort II (standard Quitline materials)Active comparatorParticipants receive standard Quitline materials in the mail on study.
Receives: Behavioral: Smoking Cessation Intervention
Group I (educational material by mail)ExperimentalParticipants receive an educational flyer by mail along with the standard Quitline materials on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.
Receives: Other: Educational Intervention; Other: Internet-Based Intervention; Behavioral: Smartphone Application-based Intervention; Behavioral: Smoking Cessation Intervention
Group III (educational messaging by text)ExperimentalParticipants receive an educational message by text along with the standard Quitline materials by mail on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.
Receives: Other: Internet-Based Intervention; Behavioral: Smartphone Application-based Intervention; Behavioral: Smoking Cessation Intervention; Other: Text Message-Based Navigation Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Engagement with quick response (QR) code scans

    QR code will be scanned will be tracked through unique uniform resource locator assigned. Each scan will be documented, allowing for the counting of interactions (Poisson) directly affiliated with the materials distributed. Also, binary (yes/no) (Did the participant interact at least once). Will be analyzed using chi-square tests or Fisher's exact tests. Bonferroni's correction will be used to adjust for three pairwise comparisons (alpha=0.05/3).

    Measured: Up to 12 months

  2. Website Utilization

    total number of visits, unique visitors,

    Measured: Up to 12 months

  3. Interactions with online resources

    Interactions with online resources will include the number of clicks on website, and time spent on various pages. Will be analyzed using chi-square tests or Fisher's exact tests. Bonferroni's correction will be used to adjust for three pairwise comparisons (alpha=0.05/3).

    Measured: Up to 12 months

  4. Website utilization

    Duration of sessions

    Measured: Up to 12 months

Secondary outcomes (6)
  1. Number of website interactions from the mailed flyer

    Will measure participant engagement with the menthol educational materials.

    Measured: Up to 12 months

  2. Number of QR code interactions from the mailed flyer

    Will measure participant engagement with the menthol educational materials.

    Measured: Up to 12 months

  3. Number of website interactions from the text message

    Will measure participant engagement with the menthol educational materials.

    Measured: Up to 12 months

  4. Number of QR code interactions from the text message

    Will measure participant engagement with the menthol educational materials.

    Measured: Up to 12 months

  5. Duration spent on the cessation website

    Will assess depth of engagement.

    Measured: Up to 12 months

  6. Number of pages or resources accessed on the website

    Will evaluate participant utilization of the content.

    Measured: Up to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2026
  2. Study start8 Aug 2025
  3. Primary completion12 Dec 2025
  4. Study completion12 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07857681
Sponsor's protocol ID
I-4464925
Other IDs
NCI-2025-03221, I-4464925
Status last verified
Sep 2026
First submitted
21 Sep 2026
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Educational Intervention, Internet-Based Intervention and Smartphone Application-based Intervention in people with Cigarette Smoking-Related Carcinoma, run by Roswell Park Cancer Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Engagement with quick response (QR) code scans (time frame: Up to 12 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in